Help support me in my mission to provide free, high-quality pharmacology education.

You can do that by going to med-ed101.com slash nurse and checking out the Med-Ead 101

Nursing Pharmacology Review Course.

I'm going to cover the basics with atrial fibrillulation and obviously focus on the most commonly used medications here.

So some generalized symptoms of atrophibulation, it can be generalized fatigue,

but most patients are going to report a feeling of fluttering, a thumping in their chest,

some dizziness can happen with that fatigue as well, and just a sensation of their heart racing.

Other things that can be associated with it, you know, shortness of breath, feeling faint, confusion, and exercise can exacerbate that fatigue as well.

All right, so medication-wise, we typically try to control the heart rate with medications.

And I went over beta blockers. I touched on calcium channel

blockers a little bit as well within the hypertension section. But really beta blockers are

going to be the first line agent with calcium channel blockers. Important distinction here,

it's going to be non-dihydropyridine calcium channel blockers,

so that would be like diltiasm or rapamil.

And then did joxin, which is a new medication to us in this webinar.

Okay, so clinical medication pearls, beta blockers I alluded to, usually first line, with metoprolol, being the most commonly used agent that I've seen in practice.

We generally avoid the non-selected beta blockers like propranol because we don't want to impact.

There's no reason to block beta two receptors.

Remember beta 1. Those are the receptors on the heart. And by blocking that, we can help reduce the heart rate. Calcium channel

blockers, non-dihydropyrodin, deltides and verapumel. Recall that they work on the heart, not just the vessels,

comparing to the dihydropyridines like amylotapine. So by working on the heart and having that

action, slowing the heart's action, we can bring down the heart rate and obviously help

...